| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | -4.67% | +2.01% | -6.68% | -6.68% | — |
| 14d | 2 | +100.00% | -2.35% | +1.27% | -3.62% | -3.62% | — |
| 30d | 2 | +100.00% | -28.36% | -2.42% | -25.94% | -25.94% | — |
| 60d | 2 | +100.00% | -42.78% | -5.15% | -37.63% | -37.63% | — |
| 90d | 2 | +100.00% | -48.23% | +3.40% | -51.63% | -51.63% | — |
| 180d | 2 | +50.00% | -1.89% | +14.72% | -16.61% | -16.61% | — |
| 1y | 2 | +0.00% | +4.98% | +29.08% | -24.09% | -24.09% | — |
| 2y | 2 | +100.00% | -81.38% | +49.48% | -130.86% | -130.86% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| STRO SUTRO BIOPHARMA, INC. | SALE Chief Business Officer | 15,428 | $4.71 | $72.6K | 0 | Aug 28, 2023 | Aug 29, 2023 ↗ | View → |
| STRO SUTRO BIOPHARMA, INC. | SALE Chief Business Officer | 11,613 | $4.59 | $53.3K | 12,928 | Aug 25, 2023 | Aug 28, 2023 ↗ | View → |
| STRO SUTRO BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 27,500 | — | — | 27,500 | Mar 3, 2023 | Mar 7, 2023 ↗ | View → |
| STRO SUTRO BIOPHARMA, INC. | SALE Chief Business Officer | 6,750 | — | — | 20,250 | Mar 3, 2023 | Mar 7, 2023 ↗ | View → |
| STRO SUTRO BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Mar 3, 2023 | Mar 7, 2023 ↗ | View → |
| STRO SUTRO BIOPHARMA, INC. | PURCHASE Chief Business Officer | 4,375 | — | — | 29,077 | Mar 3, 2023 | Mar 7, 2023 ↗ | View → |
| STRO SUTRO BIOPHARMA, INC. | SALE Chief Business Officer | 4,375 | — | — | 8,750 | Mar 3, 2023 | Mar 7, 2023 ↗ | View → |
| STRO SUTRO BIOPHARMA, INC. | SALE Chief Business Officer | 4,536 | $5.79 | $26.3K | 25,541 | Mar 3, 2023 | Mar 7, 2023 ↗ | View → |
| STRO SUTRO BIOPHARMA, INC. | PURCHASE Chief Business Officer | 6,750 | — | — | 24,702 | Mar 3, 2023 | Mar 7, 2023 ↗ | View → |